Ms. Laurie Little reports

VALEANT PHARMACEUTICALS ANNOUNCES 2013 ANNUAL MEETING RESULTS

Ten directors were elected at Valeant Pharmaceuticals International Inc.'s 2013 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out in the attached table.

Name                        For     Withheld 
                                        
Ronald H. Farmer     235,731,93   41,964,748 
Robert A. Ingram     233,865,876   3,830,806 
Theo Melas-Kyriazi   237,081,508     615,174  
G. Mason Morfit      235,623,283   2,073,399 
J. Michael Pearson   232,521,825   5,174,857 
Robert N. Power      235,168,850   2,527,832 
Norma A. Provencio   237,125,741     570,941  
Howard B. Schiller   221,521,559  16,175,123
Lloyd M. Segal       236,082,529   1,614,153 
Katharine Stevenson  234,501,146   3,195,536 

At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement; appointed PricewaterhouseCoopers LLP (United States) as the company's independent registered public accounting firm until the close of the company's 2014 annual meeting of shareholders; and approved the continuance of the company from the Canada Business Corporations Act to the British Columbia Business Corporations Act.

The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the company's website.